ProQR Therapeutics NV (NASDAQ:PRQR)

Delayed Data
As of Nov 26
 -0.17 / -2.31%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for ProQR Therapeutics NV have a median target of 21.44, with a high estimate of 36.90 and a low estimate of 17.00. The median estimate represents a +195.78% increase from the last price of 7.25.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in ProQR Therapeutics NV. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 1.10%
Growthannually 2.24%


Growthquarterly -2.16%
Growthannually -71.77%
Key to the earnings and sales forecast charts.